Eruptive squamous cell carcinomas in metastatic melanoma: An unintended consequence of immunotherapy
Publication
, Journal Article
Haraszti, S; Polly, S; Ezaldein, HH; Rothbaum, R; Delost, GR; Beveridge, M
Published in: Jaad Case Reports
June 1, 2019
Duke Scholars
Published In
Jaad Case Reports
DOI
EISSN
2352-5126
Publication Date
June 1, 2019
Volume
5
Issue
6
Start / End Page
514 / 517
Related Subject Headings
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Haraszti, S., Polly, S., Ezaldein, H. H., Rothbaum, R., Delost, G. R., & Beveridge, M. (2019). Eruptive squamous cell carcinomas in metastatic melanoma: An unintended consequence of immunotherapy. Jaad Case Reports, 5(6), 514–517. https://doi.org/10.1016/j.jdcr.2019.03.014
Haraszti, S., S. Polly, H. H. Ezaldein, R. Rothbaum, G. R. Delost, and M. Beveridge. “Eruptive squamous cell carcinomas in metastatic melanoma: An unintended consequence of immunotherapy.” Jaad Case Reports 5, no. 6 (June 1, 2019): 514–17. https://doi.org/10.1016/j.jdcr.2019.03.014.
Haraszti S, Polly S, Ezaldein HH, Rothbaum R, Delost GR, Beveridge M. Eruptive squamous cell carcinomas in metastatic melanoma: An unintended consequence of immunotherapy. Jaad Case Reports. 2019 Jun 1;5(6):514–7.
Haraszti, S., et al. “Eruptive squamous cell carcinomas in metastatic melanoma: An unintended consequence of immunotherapy.” Jaad Case Reports, vol. 5, no. 6, June 2019, pp. 514–17. Scopus, doi:10.1016/j.jdcr.2019.03.014.
Haraszti S, Polly S, Ezaldein HH, Rothbaum R, Delost GR, Beveridge M. Eruptive squamous cell carcinomas in metastatic melanoma: An unintended consequence of immunotherapy. Jaad Case Reports. 2019 Jun 1;5(6):514–517.
Published In
Jaad Case Reports
DOI
EISSN
2352-5126
Publication Date
June 1, 2019
Volume
5
Issue
6
Start / End Page
514 / 517
Related Subject Headings
- 3202 Clinical sciences